KIT and mucosal melanoma: At present, some studies have found that mutations that activate SF3B1 and KIT, the deletion of CDKN2A, PTEN, or SPRED1, and the amplification of CDK4, TERT, KIT, MDM2, or CCND1 are common in mucosal melanoma.